483
Actavis Laboratories UT, Inc.FDA 483 - Actavis Laboratories UT, Inc. - August 20, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Actavis Laboratories UT, a wholly owned subsidiary of Teva Pharmaceutical, in Salt Lake City, UT, from August 16-20, 2021, identified one observation. The firm was cited for failing to properly store and segregate labeling materials from other drug components. This indicates a deficiency in their packaging and labeling system.
Open in Dashboard
ID · 101cbdfb-b214-4afb-b2fc-acfe03827d83